WITHDRAWN: Treatment discontinuation with selective serotonin reuptake inhibitors (SSRIs) versus tricyclic antidepressants (TCAs).

WITHDRAWN: Treatment discontinuation with selective serotonin reuptake inhibitors (SSRIs) versus tricyclic antidepressants (TCAs).

BACKGROUND: Selective serotonin reuptake inhibitors are thought to have better discontinuation rates (i.e. less people dropping out) than tricyclic and heterocyclic antidepressant drugs. It is important to quantify the drop-out rates of different antidepressant drugs in order to have a better under...

Descripció completa

Dades bibliogràfiques
Autors principals:	Barbui, C, Hotopf, M, Freemantle, N, Boynton, J, Churchill, R, Eccles, M, Geddes, JR, Hardy, R, Lewis, G, Mason, J
Format:	Journal article
Idioma:	English
Publicat:	2006

Ítems similars

Treatment discontinuation with selective serotonin reuptake inhibitors (SSRIs) versus tricyclic antidepressants (TCAs) (Withdrawn Paper. 2006, art no. CD002791)
per: Barbui, C, et al.
Publicat: (2006)

WITHDRAWN: Selective serotonin reuptake inhibitors (SSRIs) versus other antidepressants for depression.
per: Geddes, J, et al.
Publicat: (2006)

Selective serotonin reuptake inhibitors versus tricyclic and heterocyclic antidepressants: comparison of drug adherence.
per: Barbui, C, et al.
Publicat: (2000)

A comparative study of personality aspects of females with depression using the antidepressant medications: selective serotonin reuptake inhibitors (SSRIs) and tricyclic antidepressants (TCAs)
per: Saeed Pournaghash tehrani, et al.
Publicat: (2018-03-01)

SSRIs versus other antidepressants for depressive disorder.
per: Geddes, J, et al.
Publicat: (2000)

Quality use of medicines: Weighing SSRIs and TCAs
per: Andy Gray
Publicat: (2003-06-01)

Side-effect profile of fluoxetine in comparison with other SSRIs, tricyclic and newer antidepressants: a meta-analysis of clinical trial data.
per: Brambilla, P, et al.
Publicat: (2005)

Selective serotonin reuptake inhibitors. Drugs related to tricyclic antidepressants are a mixed bag.
per: Cowen, P, et al.
Publicat: (1994)

The Anti-Inflammatory Potential of Tricyclic Antidepressants (TCAs): A Novel Therapeutic Approach to Atherosclerosis Pathophysiology
per: Majid Eslami, et al.
Publicat: (2025-01-01)

Early onset of selective serotonin reuptake inhibitor antidepressant action: systematic review and meta-analysis.
per: Taylor, M, et al.
Publicat: (2006)

Selective serotonin reuptake inhibitors and violent crime: do SSRI’s kill or cure?
per: S. Sneep, et al.
Publicat: (2022-06-01)

A randomised controlled trial to compare the cost-effectiveness of tricyclic antidepressants, selective serotonin reuptake inhibitors and lofepramine
per: R Peveler, et al.
Publicat: (2005-05-01)

Using functional neuroimaging to investigate the mechanisms of action of selective serotonin reuptake inhibitors (SSRIs).
per: Murphy, SE
Publicat: (2010)

Medical resource use and cost of venlafaxine or tricyclic antidepressant therapy. Following selective serotonin reuptake inhibitor therapy for depression.
per: Griffiths, R, et al.
Publicat: (1999)

The role of selective serotonin reuptake inhibitors and tricyclic antidepressants in addressing reduction of Meniere's disease burden: A scoping review
per: Alexander A. Missner, et al.
Publicat: (2024-09-01)

Efficacy of Selective Serotonin Reuptake Inhibitors (SSRIS) compared to placebo in obsessive compulsive disorder in adults
per: Soomro, G, et al.
Publicat: (2008)

Review on Surface-Modified Electrodes for the Enhanced Electrochemical Detection of Selective Serotonin Reuptake Inhibitors (SSRIs)
per: Simone C. L. Barry, et al.
Publicat: (2023-06-01)

Early effects of selective serotonin reuptake inhibitors (SSRIs) on cornea and lens density in patients with depression
per: Yalçın Karaküçük, et al.
Publicat: (2019-10-01)

In-hospital predictors of post-stroke depression for targeted initiation of Selective Serotonin Reuptake Inhibitors (SSRIs)
per: Julie Yi, et al.
Publicat: (2022-11-01)

The impacts of the “4+7” pilot policy on the volume, expenditures, and daily cost of Serotonin-Specific Reuptake Inhibitors (SSRIs) antidepressants: A quasi-experimental study
per: Xiaotong Wen, et al.
Publicat: (2022-08-01)

Selective serotonin reuptake inhibitors (SSRIs) in women of reproductive age: a systematic review of local formularies
per: Elizabeth Lovegrove, et al.
Publicat: (2024-07-01)

Adjunct Triptorelin in the Treatment of Obsessive-Compulsive Disorder in Clients Receiving Selective Serotonin Reuptake Inhibitors (SSRIs)
per: Faezeh Nikzad, et al.
Publicat: (2021-09-01)

Suicide attempt with selective serotonin reuptake inhibitor antidepressants
per: Sandra Cuenca Carcelén, et al.
Publicat: (2021-01-01)

Selective serotonin reuptake inhibitors.
per: Geddes, J, et al.
Publicat: (2004)

Impact of tricyclic antidepressants, selective serotonin reuptake inhibitors, and other antidepressants on overall survival of patients with advanced lung cancer from 2004 to 2014: University of Cincinnati experience
per: Nagla Fawzy Abdel Karim, et al.
Publicat: (2019-12-01)

Serotonin selective reuptake inhibitors (SSRIs) and female sexual dysfunction (FSD): hypothesis on its association and options of treatment
per: Mahamad Rappek, Nurul Azmi, et al.
Publicat: (2018)

Analytical methods for determination of selective serotonin reuptake inhibitor antidepressants
per: Şentürk Zühre, et al.
Publicat: (2011-06-01)

Effectiveness of selective serotonin reuptake inhibitors - Response
per: Barbui, C, et al.
Publicat: (2008)

Pindolol augmentation of serotonin reuptake inhibitors for the treatment of depressive disorder: a systematic review.
per: Whale, R, et al.
Publicat: (2010)

Myoclonus as a Single Side Effect of Combination of Selective Serotonin Reuptake Inhibitors (SSRIs) and Clomipramine: Three Case Reports
per: Reza Mohseni-Bandpey, et al.
Publicat: (2020-07-01)

Selective Serotonin Reuptake Inhibitors (SSRIs) and the Risk of Congenital Heart Defects: A Meta‐Analysis of Prospective Cohort Studies
per: Shang Wang, et al.
Publicat: (2015-05-01)

Do selective serotonin reuptake inhibitors cause suicide? Suicide rate of 15% in editorial is misleading - Reply
per: Cipriani, A, et al.
Publicat: (2005)

Antidepressants are selective serotonin neuronal reuptake inhibitors: 40-year history
per: D. S. Danilov
Publicat: (2015-03-01)

Selective serotonin reuptake inhibitor (SSRI) antidepressants, prolactin and breast cancer
per: Janet eAshbury, et al.
Publicat: (2012-12-01)

Serotonin reuptake inhibitors in Obsessive-Compulsive Disorder: antidepressant or antiobsessional agents?
per: Giuseppe Maina, et al.
Publicat: (2009-03-01)

Selective serotonin reuptake inhibitor (SSRI) antidepressant treatment discontinuation syndrome: A review of the clinical evidence and the possible mechanisms involved
per: Thibault eRenoir
Publicat: (2013-04-01)

Which of available selective serotonin reuptake inhibitors (SSRIs) is more effective in treatment of premature ejaculation? A randomized clinical trial
per: Soheila Siroosbakht, et al.
Publicat: (2019-12-01)

Selective serotonin reuptake inhibitors (SSRIs) prevent meta-iodobenzylguanidine (MIBG) uptake in platelets without affecting neuroblastoma tumor uptake
per: Thomas Blom, et al.
Publicat: (2020-07-01)

Is the Antidepressant Activity of Selective Serotonin Reuptake Inhibitors Mediated by Nicotinic Acetylcholine Receptors?
per: Hugo R. Arias, et al.
Publicat: (2021-04-01)

Review of the Knowledge on Selective Serotonin Reuptake Inhibitors (SSRIs) for Depression Management by Residents and Concurrent Physicians of the Medical Clinic of 5 Hospitals in CABA
per: Gonzalo E. Barbosa Eyler, et al.
Publicat: (2023-09-01)